Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity

Rheumatology

Volumn 46, Issue 10, 2007, Pages 1566-1569

  Caramaschi, Paola ^a   Canestrini, S ^a   Martinelli, N ^a   Volpe, A ^a   Pieropan, S ^a   Ferrari, M ^a   Bambara, L M ^a   Carletto, A ^a   Biasi, D ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Nailfold videocapillaroscopy; Systemic sclerosis

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; CAPILLAROSCOPY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FINGER NAIL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROGNOSIS; SCLERODERMA; SEX DIFFERENCE; SKIN BLOOD FLOW; VASCULAR DISEASE; VIDEORECORDING;

ADULT; AGED; CAPILLARIES; FEMALE; HUMANS; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; PERIPHERAL VASCULAR DISEASES; PHENOTYPE; PROGNOSIS; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 34848818045     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem190     Document Type: Article

References (27)

1. Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
2. Derk CT, Jimenez SA. Systemic sclerosis: Current view of its pathogenesis. Aut Rev 2003;2:181-91.
3. Pignone A, Scaletti C, Matucci-Cerinic M et al. Anti-endothelial cell antibodies in systemic sclerosis: Significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998;16:527-32.
4. Lunardi C, Bason C, Navone R et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000;6:1183-6.
5. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62.
6. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 2001;19:4-8.
7. Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL. Computerized nailfold videocapillaroscopy - a new tool for assessment of Raynaud's phenomenon. J Rheumatol 2005;32:841-8.
8. Cutolo M, Pizzorni C, Sulli A. Capilalroscopy. Best Pract Res Clin Rheumatol 2005;19:437-52.
9. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-30.
10. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. LeRoy EC, Black CM, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
12. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
13. Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR. Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 2002;21(Suppl 29):S5-8.
14. Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21(Suppl 29):S42-6.
15. Valentini G, Della Rossa A, Bombardieri S et al. European multicentre study to define disease activity for systemic sclerosis. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001;60:592-8.
16. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:2722-3.
17. Cutolo M, Pizzorni C, Tuccio M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26.
18. Matucci-Cerinic M, D'Angelo S, Denton CP, Vlachoyannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol 2003;21(Suppl 29):S19-23.
19. Groen H, Wichers G, ter Borg EJ, van der Mark TW, Vouda AA, Kallemberg CG. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease. Am J Med 1990;89:34-41.
20. Steen VD. Autoantibodies in systemic sclerosis. Seminars Arthritis Rheum 2005;35:35-42.
21. Simeon CP, Armadans L, Fonollosa V et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 2003;42:71-5.
22. Denton CP, Bickerstaff MC, Shiwen X et al. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol 1995;34:1048-54.
23. Yanaba K, Hasegawa M, Takehara K, Sato S. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J Rheumatol 2004;31:1112-20.
24. Asano Y, Ihn H, Yamane K et al. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum 2001;44:1363-9.
25. Meyer O. Prognostic markers for systemic sclerosis. Joint Bone Spine 2006;73:490-4.
26. Caramaschi P, Martinelli N, Biasi D et al. Homocysteine plasma level is related to the severity of lung impairment in scleroderma. J Rheumatol 2003;30:298-304.
27. Caramaschi P, Volpe A, Canestrini S et al. Correlation between homocysteine plasma levels and nailfold videocapillaroscopic patterns in systemic sclerosis. Clin Rheumatol 2006, Oct 18; [Epub ahead of print].